Epha3 acts as proangiogenic factor in multiple myeloma.

about

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.Smenamide A Analogues. Synthesis and Biological Activity on Multiple Myeloma Cells.

P2860

Q51808808-CB824EF3-5C34-4ED3-A433-C7C17CD7EB21 Q55455557-D9EF4E9B-16F3-43D8-86C2-8E5D709E879E

P2860

Epha3 acts as proangiogenic factor in multiple myeloma.

Item

http://www.wikidata.org/entity/Q42174452

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Epha3 acts as proangiogenic factor in multiple myeloma.

@en

Epha3 acts as proangiogenic factor in multiple myeloma.

@nl

type

Item

label

Epha3 acts as proangiogenic factor in multiple myeloma.

@en

Epha3 acts as proangiogenic factor in multiple myeloma.

@nl

prefLabel

Epha3 acts as proangiogenic factor in multiple myeloma.

@en

Epha3 acts as proangiogenic factor in multiple myeloma.

@nl

P1476

Epha3 acts as proangiogenic factor in multiple myeloma.

@en

P2093

Angelo Vacca

http://www.w3.org/2001/XMLSchema#string

Antonio Basile

http://www.w3.org/2001/XMLSchema#string

Daniela Cilloni

http://www.w3.org/2001/XMLSchema#string

Luciana De Luca

http://www.w3.org/2001/XMLSchema#string

Luigi Del Vecchio

http://www.w3.org/2001/XMLSchema#string

Oreste Villani

http://www.w3.org/2001/XMLSchema#string

Pellegrino Musto

http://www.w3.org/2001/XMLSchema#string

Roberto Tamma

http://www.w3.org/2001/XMLSchema#string

Simona Berardi

http://www.w3.org/2001/XMLSchema#string

Stefania Trino

http://www.w3.org/2001/XMLSchema#string

P2860

Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling

Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines

Eph/ephrin molecules--a hub for signaling and endocytosis

Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

European perspective on multiple myeloma treatment strategies in 2014

Eph receptors and ephrins: regulators of guidance and assembly

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line

PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature

P304

34298-34309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16100

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28415715

http://www.w3.org/2001/XMLSchema#string

P932

5470968

http://www.w3.org/2001/XMLSchema#string

Epha3 acts as proangiogenic factor in multiple myeloma.

about

P2860

P2860

Epha3 acts as proangiogenic factor in multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932